World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
17922
World Ranking
2577
National Ranking
102

Thomas W. H. Kay publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas W. H. Kay sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 230 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas W. H. Kay D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas W. H. Kay sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Thomas W. H. Kay is affiliated with the University of Melbourne in Australia. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a focused engagement in Surgery, Genetics, Endocrinology, Diabetes and Metabolism, Immunology, and Pharmacology as subfields of study.

The scientific work of Thomas W. H. Kay concentrates heavily on topics related to pancreatic function and diabetes, diabetes and associated disorders, and diabetes management and research. Additional areas of interest include immune cell function and interaction, cannabis and cannabinoid research, T-cell and B-cell immunology, and renal transplantation outcomes and treatments.

Significant recent publications by Thomas W. H. Kay include:

  • "Baricitinib and β-Cell Function in Patients with New-Onset Type 1 Diabetes" (2023), published in New England Journal of Medicine
  • "Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry" (2023), published in The Lancet Diabetes & Endocrinology
  • "The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice" (2020), published in Frontiers in Immunology
  • "Inflammation versus regulation: how interferon-gamma contributes to type 1 diabetes pathogenesis" (2023), published in Frontiers in Cell and Developmental Biology
  • "A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation" (2022), published in Transplant International

Thomas W. H. Kay frequently publishes in the following venues:

  • Transplantation
  • Diabetes
  • Frontiers in Immunology
  • Diabetes Care
  • The Lancet Diabetes & Endocrinology

Collaborations have been established extensively with colleagues including Helen E. Thomas, Balasubramanian Krishnamurthy, Thomas Loudovaris, Gaurang Jhala, and Prerak Trivedi, with co-authorships reaching up to 24 joint publications with these researchers.

Best Publications

  • Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity.

    Philippe Bouillet;Donald Metcalf;David C. S. Huang;David M. Tarlinton

  • SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this Cytokine

    Warren S Alexander;Robyn Starr;Robyn Starr;Jennifer E Fenner;Clare L Scott;Clare L Scott

  • Improvement in outcomes of clinical islet transplantation: 1999-2010.

    Franca B. Barton;Michael R. Rickels;Rodolfo Alejandro;Bernhard J. Hering

  • Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients

    Ken T. Coppieters;Francesco Dotta;Natalie Amirian;Peter D. Campbell

  • Tumor necrosis factor α-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling

    Gregory r Steinberg;Belinda J Michell;Bryce J W Jw van Denderen;Matthew James Watt

  • Granulocyte Macrophage Colony-Stimulating Factor A New Putative Therapeutic Target in Multiple Sclerosis

    Jonathan Luke McQualter;Rima Darwiche;Christine Ewing;Manabu Onuki

  • Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice.

    I. L. Campbell;T. W. H. Kay;L. Oxbrow;L. C. Harrison

  • Transgenic Expression of Mouse Proinsulin II Prevents Diabetes in Nonobese Diabetic Mice

    Michelle B French;Janette Allison;David S Cram;Helen E Thomas

  • Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP

    Balasubramanian Krishnamurthy;Nadine L. Dudek;Mark D. McKenzie;Anthony W. Purcell

  • The insulin A-chain epitope recognized by human T cells is posttranslationally modified.

    Stuart I. Mannering;Leonard C. Harrison;Nicholas A. Williamson;Jessica S. Morris

  • Beta cell apoptosis in diabetes

    Helen E. Thomas;Helen E. Thomas;Mark D. McKenzie;Mark D. McKenzie;Eveline Angstetra;Eveline Angstetra;Peter D. Campbell;Peter D. Campbell

  • Interleukin-1 Plus γ-Interferon-Induced Pancreatic β-Cell Dysfunction Is Mediated by β-Cell Nitric Oxide Production

    Helen E. Thomas;Rima Darwiche;John A. Corbett;Thomas W.H. Kay

  • The diagnosis of insulitis in human type 1 diabetes

    M. L. Campbell-Thompson;M. A. Atkinson;A. E. Butler;N. M. Chapman

  • Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes

    Federica Vecchio;Nicola Lo Buono;Angela Stabilini;Laura Nigi

  • Suppressor of Cytokine Signaling-1 Is a Critical Regulator of Interleukin-7-Dependent CD8+ T Cell Differentiation

    Mark M.W Chong;Ann L Cornish;Rima Darwiche;Edouard G Stanley

  • IL-1 Receptor Deficiency Slows Progression to Diabetes in the NOD Mouse

    Helen E. Thomas;Windy Irawaty;Rima Darwiche;Thomas C. Brodnicki

  • IL-1β Breaks Tolerance through Expansion of CD25+ Effector T Cells

    Brendan J. O’Sullivan;Helen E. Thomas;Saparna Pai;Pere Santamaria

  • Perinatal tolerance to proinsulin is sufficient to prevent autoimmune diabetes

    Gaurang Jhala;Jonathan Chee;Prerak M Trivedi;Claudia Selck

  • Proinsulin-Specific, HLA-DQ8, and HLA-DQ8-Transdimer–Restricted CD4+ T Cells Infiltrate Islets in Type 1 Diabetes

    Vimukthi Pathiraja;Janine P. Kuehlich;Peter D. Campbell;Balasubramanian Krishnamurthy;Balasubramanian Krishnamurthy

  • International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.

    Ezio Bonifacio;Mark Atkinson;George Eisenbarth;David Serreze

Frequent Co-Authors

Leonard C. Harrison
Leonard C. Harrison University of Melbourne
Andrew M. Lew
Andrew M. Lew Walter and Eliza Hall Institute of Medical Research
Pere Santamaria
Pere Santamaria University of Calgary
Andreas Strasser
Andreas Strasser Walter and Eliza Hall Institute of Medical Research
Shane T. Grey
Shane T. Grey Garvan Institute of Medical Research
Gregory R. Steinberg
Gregory R. Steinberg McMaster University
Joseph A. Trapani
Joseph A. Trapani Peter MacCallum Cancer Centre
Mark Peakman
Mark Peakman King's College London
Yifan Zhan
Yifan Zhan Walter and Eliza Hall Institute of Medical Research
Bart O. Roep
Bart O. Roep Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals start with foundational qualifications before specializing. For example, there are excellent online RN programs for non nurses that help transition individuals from other fields into registered nursing.

Nurses often seek advanced roles by enrolling in accelerated FNP programs. These programs provide a fast track to becoming a Family Nurse Practitioner, equipping students with the skills needed for primary care and family health.

Those already certified as FNPs can consider specialization options. For instance, transitioning through an FNP to acute care certification offers a pathway to care for critically ill patients and enter high-demand acute care settings.

Career prospects vary widely, with some specialties earning higher salaries. Information on the highest paid DNP specialties highlights how advanced practice nurses in specific fields can maximize their earning potential while impacting patient care through leadership and clinical expertise.

Best Scientists Citing Thomas W. H. Kay

Trending Scientists

Recently Published Articles